Paid Clinical Trials in New Jersey

New Jersey has 1,790 paid clinical trials enrolling now across cities including New Brunswick, Hackensack and Basking Ridge. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 8, 2026.

Filter results

State

City

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

1,790 clinical trials

↓ Download CSV

MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial

for Breast Cancer

7 locations incl. Basking Ridge

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT06954337·Recruiting

Apply to this trial

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

for Atherosclerotic Cardiovascular Disease (ASCVD)

Drug: Inclisiran

37 locations incl. Birmingham

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18 - 80

Code: NCT06813911·Phase 3·Recruiting

Apply to this trial

Brain Activity Changes After Cognitive Behavioral Therapy for Anxiety in Autistic Youth From High-Need Communities

for Autism Spectrum Disorder

2 locations incl. Montclair

Sponsor: Montclair State University

Sex: All·Age: 8 - 14

Code: NCT06904508·Recruiting

Apply to this trial

An 8-week Open-label Study of an Accelerated and Slower Switching to Xanomeline/Trospium Following Atypical Antipsychotic Treatment in Participants With Schizophrenia

for Schizophrenia Disorders

7 locations incl. Bellflower

Sponsor: Collaborative Neuroscience Research, LLC

Sex: All·Age: 18 - 65

Code: NCT06924255·Phase 4·Not Yet Recruiting

An Observational Study to Learn More About Vasomotor Symptoms Burden and Treatment Patterns in Menopausal Women Before and After Participating in OASIS Studies

for Vasomotor Symptoms (VMS) Associated With Menopause

1 location in Whippany

Sponsor: Bayer

Sex: Female·Age: 40 - 65·Accepts healthy volunteers

Code: NCT06949553·Recruiting

Apply to this trial

Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.

for Hematuria - Cause Not Known

15 locations incl. Homewood

Sponsor: Pacific Edge Limited

Sex: All·Age: 18 - 88

Code: NCT06394869·Recruiting

Apply to this trial

Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder

for Generalized Anxiety Disorder (GAD)

49 locations incl. Huntsville

Sponsor: AbbVie

Sex: All·Age: 18 - 65

Code: NCT06846320·Phase 2·Recruiting

Apply to this trial

Mosaic Trial for Stem Cell Transplant Recipients

for Hematologic Malignancy

3 locations incl. Washington D.C.

Sponsor: Northwestern University

Sex: All·Age: 18+

Code: NCT06960993·Recruiting

Apply to this trial

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

for Small Cell Lung Cancer Metastatic or Locally Advanced

20 locations incl. Huntsville

Sponsor: SystImmune Inc.

Sex: All·Age: 18+

Code: NCT07080242·Phase 1·Recruiting

Apply to this trial

Multiple Sclerosis Implementation Network (Registry)

for Multiple Sclerosis

3 locations incl. Cherry Hill

Sponsor: The University of Texas Health Science Center, Houston

Sex: All·Age: 18+

Code: NCT07415824·Recruiting

Apply to this trial

Testing the Combination of Two Approved Drugs and One Experimental Drug in Patients With Relapsed or Refractory Multiple Myeloma

for Recurrent Multiple Myeloma

40 locations incl. Ames

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All·Age: 18+

Code: NCT06232044·Phase 1, Phase 2·Recruiting

Apply to this trial

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

for Locally Advanced Breast Cancer

10 locations incl. Beverly Hills

Sponsor: BioNTech SE

Sex: All·Age: 18+

Code: NCT06827236·Phase 1, Phase 2·Recruiting

Apply to this trial

A Study of Hospital-at-Home for People Receiving Tarlatamab

for Small-cell Lung Cancer

Drug: Tarlatamab

7 locations incl. Basking Ridge

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT06957314·Recruiting

Apply to this trial

Pivotal Study for the Cardiac Performance System (CPS)

for Cardiovascular Diseases

10 locations incl. Huntsville

Sponsor: Sensydia Corporation

Sex: All·Age: 18+

Code: NCT06870591·Recruiting

Apply to this trial

A Mobile Health Intervention Among Hispanics

for Cancer of Skin

1 location in New Brunswick

Sponsor: Rutgers, The State University of New Jersey

Sex: All·Age: 18 - 100·Accepts healthy volunteers

Code: NCT05389332·Recruiting

Apply to this trial

A Study of ETHIZIA Versus SURGICEL Original in Controlling Soft Tissue Bleeding During Open Surgery

for Hemostasis

6 locations incl. Los Angeles

Sponsor: Ethicon, Inc.

Sex: All·Age: 22+

Code: NCT06664788·Recruiting

Apply to this trial

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

for Stage I Mixed Cell Type Kidney Wilms Tumor

146 locations incl. Birmingham

Sponsor: Children's Oncology Group

Sex: All·Age: Up to 30

Code: NCT06401330·Phase 3·Recruiting

Apply to this trial

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

for Lymphoma, Large B-Cell, Diffuse

Drug: Polatuzumab Vedotin

70 locations incl. Mobile

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06890884·Phase 2·Recruiting

Apply to this trial

A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)

for Non-Muscle Invasive Bladder Cancer

9 locations incl. Baltimore

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 21+

Code: NCT06929286·Phase 3·Recruiting

Apply to this trial

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

for Carcinoma, Non-Small Cell Lung

Drug: Rilvegostomig

37 locations incl. La Mesa

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06868277·Phase 3·Recruiting

Apply to this trial

An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome

for Lennox Gastaut Syndrome

20 locations incl. Little Rock

Sponsor: Epygenix

Sex: All·Age: 2 - 55

Code: NCT05066217·Phase 3·Recruiting

Apply to this trial

The EPIC Study: Exploring Paternal Age and the Influence on Blastocyst Culture

for Infertility (IVF Patients)

1 location in Basking Ridge

Sponsor: Reproductive Medicine Associates of New Jersey

Sex: Female·Age: 18 - 41

Code: NCT06629766·Recruiting

Apply to this trial

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

for Breast Cancer

51 locations incl. Phoenix

Sponsor: Hoffmann-La Roche

Sex: All·Age: 18+

Code: NCT06790693·Phase 3·Recruiting

Apply to this trial

Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia

for Hypertriglyceridemia

Drug: Plozasiran

76 locations incl. Bakersfield

Sponsor: Arrowhead Pharmaceuticals

Sex: All·Age: 18+

Code: NCT06822790·Phase 3·Recruiting

Apply to this trial

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

for Ovarian Cancer

30 locations incl. Birmingham

Sponsor: Merck Sharp & Dohme LLC

Sex: Female·Age: 18+

Code: NCT06824467·Phase 3·Recruiting

Apply to this trial

Efficacy of GLP-1 Receptor Agonists in Treating Upper and Lower Extremity Lymphedema

for Lymphedema

2 locations incl. Red Bank

Sponsor: Advanced Reconstructive Surgery Alliance

Sex: All·Age: 18+

Code: NCT07012642·EARLY_Phase 1·Recruiting

Apply to this trial

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

for Extensive Stage Lung Small Cell Carcinoma

Drug: Atezolizumab

43 locations incl. Duarte

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT06287775·Phase 1, Phase 2·Recruiting

Apply to this trial

Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis

for Multiple Sclerosis, Relapsing-Remitting

12 locations incl. Loma Linda

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 10 - 17

Code: NCT06408259·Phase 3·Recruiting

Apply to this trial

Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma

for Glioblastoma

10 locations incl. Miami

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT06934889·Phase 1·Recruiting

Apply to this trial

Home Reported Outcomes in C3G Study

for C3 Glomerulopathy

1 location in East Hanover

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18 - 100

Code: NCT07029542·Recruiting

Apply to this trial

A Study of Ivonescimab in People With Endometrial and Cervical Cancers

for Endometrial Cancer

Drug: Ivonescimab

7 locations incl. Basking Ridge

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Female·Age: 18+

Code: NCT06925724·Phase 2·Recruiting

Apply to this trial

Below-the-Knee Interventions for Limb Salvage: Use of Multifunctional Angioplasty Balloon Catheters

for Peripheral Arterial Disease Below the Knee

2 locations incl. Wilmington

Sponsor: Summa Therapeutics, LLC

Sex: All·Age: 18 - 120

Code: NCT06906055·Not Yet Recruiting

Optimizing the Prehospital Use of Stroke Systems of Care-Reacting to Changing Paradigms-Implementation (OPUS-i)

for Stroke

2 locations incl. Camden

Sponsor: Temple University

Sex: All·Age: 18+

Code: NCT06530693·Recruiting

Apply to this trial

Cardiovascular Function and Response to Stimulation Within the First Year After Spinal Cord Injury

for Spinal Cord Injuries (SCI)

1 location in West Orange

Sponsor: Kessler Foundation

Sex: All·Age: 18 - 75

Code: NCT06841198·Recruiting

Apply to this trial

The Use of AR / VR in Patients Presenting to the ED With Renal Colic

for Renal Colic

1 location in Toms River

Sponsor: Community Medical Center, Toms River, NJ

Sex: All·Age: 18+

Code: NCT07070401·Recruiting

Apply to this trial

CT-95 in Advanced Cancers Associated With Mesothelin Expression

for Mesothelin-Expressing Tumors

9 locations incl. Denver

Sponsor: Context Therapeutics Inc.

Sex: All·Age: 18+

Code: NCT06756035·Phase 1·Recruiting

Apply to this trial

Self-balancing Personal Exoskeleton for SCI (Site 2)

for Spinal Cord Injuries (SCI)

1 location in West Orange

Sponsor: Wandercraft

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT06814015·Recruiting

Apply to this trial

A Study of Enfortumab Vedotin in People With Adenoid Cystic Carcinoma

for Adenoid Cystic Carcinoma

7 locations incl. Basking Ridge

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT06891560·Phase 2·Recruiting

Apply to this trial

Acupuncture for People Experiencing Period Loss Due to Chemotherapy

for Cancer

7 locations incl. Basking Ridge

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Female·Age: 15 - 40

Code: NCT06915116·Phase 2·Recruiting

Apply to this trial

Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment

for Eosinophilic Asthma

34 locations incl. Chandler

Sponsor: AstraZeneca

Sex: All·Age: 12 - 75

Code: NCT06750289·Phase 3·Recruiting

Apply to this trial